Gilead Sciences Inc

GILD: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
N?#LOCK|Q^LOCK|%?&jMyz

Gilead: Raising Our Fair Value Estimate to Incorporate Longer Biktarvy Runway

Gilead announced a settlement on Oct. 6 with three generic manufacturers, securing an agreement for them not to launch a generic version of Gilead's HIV drug Biktarvy until at least April 1, 2036, in the US.

Sponsor Center